Amanote Research

Amanote Research

    RegisterSign In

Government Insists NHS Pays for Drugs Approved by NICE

BMJ
doi 10.1136/bmj.323.7326.1386
Full Text
Open PDF
Abstract

Available in full text

Date

December 15, 2001

Authors
Z. Kmietowicz
Publisher

BMJ


Related search

Php365 - Trends and Characteristics of Managed Access Agreements Approved by Nice

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Drug Development Process and Novel Drugs Approved by FDA for 2017 -18

Applied Clinical Research, Clinical Trials and Regulatory Affairs
2018English

Repurposing FDA-approved Drugs for Anti-Aging Therapies

Biogerontology
AgingGerontologyGeriatrics
2016English

Limiting Prescribable NHS Drugs

BMJ
1984English

Opportunity Costs of Implementing Nice Decisions in NHS Wales

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Opportunity Costs of Implementing Nice Decisions in NHS Wales

SSRN Electronic Journal
2014English

Pivotal Studies of Orphan Drugs Approved for Neurological Diseases

Annals of Neurology
Neurology
2009English

NHS Faces Legal Action Over Copayment for Private Drugs While Receiving NHS Care

British Medical Journal
Medicine
2008English

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy